Literature DB >> 26021753

Managing intrathecal drug delivery (ITDD) in cancer patients.

Rajiv Shah1, Aisha Baqai-Stern, Amitabh Gulati.   

Abstract

Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient's disease course, and the management of complications related to the ITDD system and intrathecal medications.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26021753     DOI： 10.1007/s11916-015-0488-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  22 in total

1.  Epidural and intrathecal analgesia is effective in treating refractory cancer pain.

Authors:  Allen W Burton; Arun Rajagopal; Hemant N Shah; Tito Mendoza; Charles Cleeland; Samuel J Hassenbusch; James F Arens
Journal:  Pain Med       Date:  2004-09       Impact factor: 3.750

2.  Ziconotide for treatment of severe chronic pain.

Authors:  Achim Schmidtko; Jörn Lötsch; Rainer Freynhagen; Gerd Geisslinger
Journal:  Lancet       Date:  2010-04-21       Impact factor: 79.321

3.  Pharmaceutical approval update.

Authors:  Marvin M Goldenberg
Journal:  P T       Date:  2011-02

4.  Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations.

Authors:  Laurie L Ackerman; Kenneth A Follett; Richard W Rosenquist
Journal:  J Pain Symptom Manage       Date:  2003-07       Impact factor: 3.612

5.  Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.

Authors:  Thomas J Smith; Peter S Staats; Timothy Deer; Lisa J Stearns; Richard L Rauck; Richard L Boortz-Marx; Eric Buchser; Elena Català; David A Bryce; Patrick J Coyne; George E Pool
Journal:  J Clin Oncol       Date:  2002-10-01       Impact factor: 44.544

6.  Intrathecal pain pump infusions for intractable cancer pain: an algorithm for dosing without a neuraxial trial.

Authors:  Vivek Tim Malhotra; James Root; Joseph Kesselbrenner; Innocent Njoku; Kenneth Cubert; Amitabh Gulati; Vinay Puttanniah; Mark Bilsky; Michael Kaplitt
Journal:  Anesth Analg       Date:  2013-04-04       Impact factor: 5.108

Review 7.  Neuraxial pain relief for intractable cancer pain.

Authors:  Paul A Sloan
Journal:  Curr Pain Headache Rep       Date:  2007-08

8.  Polyanalgesic Consensus Conference--2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.

Authors:  Timothy R Deer; Joshua Prager; Robert Levy; Allen Burton; Eric Buchser; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael Erdek; Eric Grigsby; Marc Huntoon; Marilyn Jacobs; Phillip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil J Panchal; Richard Rauck; Michael Saulino; Peter Staats; Michael Stanton-Hicks; Lisa Stearns; B Todd Sitzman; Mark Wallace; K Dean Willis; William Witt; Tony Yaksh; Nagy Mekhail
Journal:  Neuromodulation       Date:  2012-04-11

9.  Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.

Authors:  Timothy R Deer; Joshua Prager; Robert Levy; James Rathmell; Eric Buchser; Allen Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael Erdek; Eric Grigsby; Marc Huntoon; Marilyn S Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone C McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B Todd Sitzman; Peter Staats; Michael Stanton-Hicks; Lisa Stearns; Mark Wallace; K Dean Willis; William Witt; Tony Yaksh; Nagy Mekhail
Journal:  Neuromodulation       Date:  2012-07-02

10.  Medical cost impact of intrathecal baclofen therapy for severe spasticity.

Authors:  Michael Saulino; Scott Guillemette; Jacqueline Leier; Jennifer Hinnenthal
Journal:  Neuromodulation       Date:  2014-08-21
View more
  3 in total

1.  Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.

Authors:  K Bey; C Ciron; L Dubreil; J Deniaud; M Ledevin; J Cristini; V Blouin; P Aubourg; M-A Colle
Journal:  Gene Ther       Date:  2017-04-20       Impact factor: 5.250

Review 2.  The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.

Authors:  Mansoor M Aman; Ammar Mahmoud; Timothy Deer; Dawood Sayed; Jonathan M Hagedorn; Shane E Brogan; Vinita Singh; Amitabh Gulati; Natalie Strand; Jacqueline Weisbein; Johnathan H Goree; Fangfang Xing; Ali Valimahomed; Daniel J Pak; Antonios El Helou; Priyanka Ghosh; Krishna Shah; Vishal Patel; Alexander Escobar; Keith Schmidt; Jay Shah; Vishal Varshney; William Rosenberg; Sanjeet Narang
Journal:  J Pain Res       Date:  2021-07-16       Impact factor: 3.133

Review 3.  Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.

Authors:  Viorel Simion; Wissem Deraredj Nadim; Helene Benedetti; Chantal Pichon; Severine Morisset-Lopez; Patrick Baril
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.